(S (NP (VBN Personalized) (NN cancer) (NNS vaccines)) (VP (VBP are) (VP (VBN envisioned) (PP (IN as) (NP (DT the) (JJ next) (NN generation) (JJ rational) (NN cancer) (NN immunotherapy))))) (. .))
(S (NP (NP (DT The) (JJ key) (NN step)) (PP (IN in) (S (VP (VBG developing) (NP (JJ personalized) (JJ therapeutic) (NN cancer) (NNS vaccines)))))) (VP (VBZ is) (S (VP (TO to) (VP (VB identify) (NP (NP (JJ tumor-specific) (NNS neoantigens)) (SBAR (WHNP (WDT that)) (S (VP (VBP are) (PP (IN on) (NP (NP (DT the) (NN surface)) (PP (IN of) (NP (NN tumor) (NNS cells))))))))))))) (. .))
(S (NP (NP (DT A) (JJ promising) (NN method)) (PP (IN for) (NP (DT this)))) (VP (VBZ is) (PP (IN through) (NP (NP (FW de) (FW novo) (IN peptide) (VBG sequencing)) (PP (IN from) (NP (NN mass) (NN spectrometry) (NNS data)))))) (. .))
(S (PP (IN In) (NP (DT this) (NN paper))) (NP (PRP we)) (VP (VBP introduce) (NP (NP (NNP DeepNovoV2)) (, ,) (NP (NP (DT the) (JJ state-of-the-art) (NN model)) (PP (IN for) (NP (JJ peptide) (NN sequencing)))))) (. .))
(S (S (PP (IN In) (NP (NNP DeepNovoV2))) (, ,) (NP (DT a) (NN spectrum)) (VP (VBZ is) (VP (ADVP (RB directly)) (VBN represented) (PP (IN as) (NP (NP (DT a) (NN set)) (PP (IN of) (NP (PRN (-LRB- -LRB-) (NN m/z) (, ,) (NN intensity) (-RRB- -RRB-)) (NN pairs)))))))) (, ,) (S (ADVP (IN therefore)) (NP (PRP it)) (VP (VBZ does) (RB not) (VP (VB suffer) (PP (IN from) (NP (DT the) (JJ accuracy-speed/memory) (NN trade-off) (NN problem)))))) (. .))
(S (NP (DT The) (NN model)) (VP (VP (VBZ combines) (NP (NP (NP (DT an) (NN order) (JJ invariant) (NN network) (NN structure)) (PRN (-LRB- -LRB-) (NP (NNP T-Net)) (-RRB- -RRB-))) (CC and) (NP (JJ recurrent) (JJ neural) (NNS networks)))) (CC and) (VP (VBZ provides) (NP (NP (DT a) (JJ complete) (JJ end-to-end) (NN training) (CC and) (NN prediction) (NN framework)) (SBAR (S (VP (TO to) (VP (VB sequence) (NP (NP (NNS patterns)) (PP (IN of) (NP (NNS peptides))))))))))) (. .))
